정규장
Log in Sign up
PRFX
PRFX
PRF Technologies Ltd
7월 28일 2:23 PM ET (한국 7/29 03:23)
$1.09
-0.04 ▼ -3.96%

프리에프 테크놀러지즈(PRFX) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$3M
스몰캡
P/E
-
배당수익률
없음
52주 위치
0%
저점 -1% · 고점 -94%
애널리스트
적극 매수
B-
Fundamental health
vs. Drug Manufacturers - Specialty & Generic 초소형주· based on 3 axes
수익성 ⓘ
산출 불가 (적자)
성장 ⓘ
Top 12%
밸류에이션 ⓘ
Top 44%
재무 안정 ⓘ
Top 64%
Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -8.49Insider Own ⓘ -Shs Outstand ⓘ 0.0MPerf Week ⓘ -5.22%
Market Cap ⓘ 0.00BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ -Perf Month ⓘ -31.87%
Enterprise Value ⓘ -0.00BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 11.47%Short Float ⓘ -Perf Quarter ⓘ -52.19%
Income ⓘ -0.00BP/S ⓘ 165.66EPS this Y ⓘ -Inst Trans ⓘ 0.64%Short Ratio ⓘ 0.06Perf Half Y ⓘ -72.19%
Sales ⓘ 0.00BP/B ⓘ 0.11EPS next 5Y ⓘ -ROA ⓘ -Short Interest ⓘ 0.15MPerf YTD ⓘ -66.03%
Book/sh ⓘ 10.29P/C ⓘ 0.79EPS past 3/5Y ⓘ 80.39% 55.23%ROE ⓘ -52W High ⓘ -93.93% ($17.95)Perf Year ⓘ -85.37%
Cash/sh ⓘ 1.37P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -56.63%52W Low ⓘ -1.09% ($1.10)Perf 3Y ⓘ -99.86%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 99.15%Gross Margin ⓘ -4864.71%Volatility(W/M) ⓘ 6.69% 9.4%Perf 5Y ⓘ -99.97%
Dividend TTM ⓘ -EV/Sales ⓘ -4.34Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -29335.29%ATR (14) ⓘ 0.17Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 1.78EPS Q/Q ⓘ -3.64%Profit Margin ⓘ -28458.82%RSI (14) ⓘ 38.47Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 1.78Sales Q/Q ⓘ -SMA20 ⓘ -13.89% ($1.27)Beta ⓘ 1.05Target Price ⓘ $240
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ -SMA50 ⓘ -27.41% ($1.5)Rel Volume ⓘ 0.13Prev Close ⓘ $1.13
Employees ⓘ 7LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -5.77% -SMA200 ⓘ -66.04% ($3.21)Avg Volume(3M) ⓘ 2.57MPrice ⓘ $1.09
IPO ⓘ 2020/9/1Option/Short ⓘ No/YesTrades ⓘ 573Volume ⓘ 335,569Change ⓘ -3.96%
Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 PRF Technologies Ltd (PRFX) Investment Analysis

What kind of company is PRF Technologies Ltd?

프리에프 테크놀러지즈(PRFX)
Healthcare · Drug Manufacturers - Specialty & Generic
Small-Cap — Low Volume, High Volatility

💊 A drug delivery platform company. Developing anesthetics and ophthalmology drugs. Expanding into AI-powered solar analysis. Pursuing a diversification strategy. As of 2025, holds $0.1M in cash.

Learn more about PRF Technologies Ltd →
Market Cap
$0.0B
Approx. KRW 0.0 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank5756
Employees7people
IPO2020/09/01
Current Price$1.09 ≈ 1,493원
NASD · Israel

Key Events

예정된 이벤트가 없습니다

PRFX의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.

  • 실적 발표는 보통 분기마다 있습니다
  • 배당주는 연 1~4회 배당락일이 있습니다
전체 경제/실적 캘린더 보기 →

Is it profitable?

Financially sound but profitability is low
Losses or thin margins — early-stage growth or weakening competitiveness
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
-29335.3%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Net Margin
Share of revenue left after taxes and interest are paid
-28458.8%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
-4864.7%
✓ 매우 부진
My positionBottom 5%
Low range Average High range
Drug Manufacturers - Specialty & Generic 초소형주 Median 26.6% · Bottom tier
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROIC
Return generated per dollar invested in the business
-56.6%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.00
✓ Very low debt
My positionTop 5%
Low range Average High range
Drug Manufacturers - Specialty & Generic Median 0.36
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
1.78
✓ 양호
My positionMid-range
Low range Average High range
Drug Manufacturers - Specialty & Generic Median 2.47
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
1.78
✓ 양호
My positionMid-range
Low range Average High range
Drug Manufacturers - Specialty & Generic Median 1.68
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$240.00
현재가 대비 +21918.3%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth
Mid-range within the industry
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+80.4%
우수
My positionTop 25%
Low range Average High range
미분류 초소형주 Median 25.4% · Top 10%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
+55.2%
우수
My positionTop 25%
Low range Average High range
미분류 초소형주 Median 14.6% · Top 15%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -168%p below the market
PRFX -100.0% · S&P 500 +68.3%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-168.3%p
Significantly behind the market
vs Health Care (XLV)
-124.5%p
Significantly behind the sector average
1-year basis
vs S&P 500
-101.4%p
Significantly behind the market
vs Health Care (XLV)
-105.1%p
Significantly behind the sector average
Rank among peers
5-year return Bottom 12% Based on 28 peers
1-year return Bottom 14% Based on 36 peers
Current position within 52-week range
Low (-1.1%p) High (-93.9%p)
Current price is 1.1% above the 52-week low and 93.9% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-68.5%
Annualized volatility
285.4%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-27
Downtrend zone

Current price $1.09 below the midline ($1.26). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴
Current diagnosis · 2026-07-27
Bearish momentum holding

MACD -0.124 < Signal -0.122 in negative zone + Hist negative (-0.001). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 38.5 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 2.7.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average
Cheap on Vs. Assets, Pricey on Vs. Sales
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
🏢 Vs. Assets Cheap
🧾 Vs. Sales Pricey
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
0.11x
✓ Very cheap
My positionTop 25%
Low range Average High range
Drug Manufacturers - Specialty & Generic 초소형주 median 0.78x · Top 12% — relatively cheap within the industry
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
165.66x
✓ Very pricey
My positionBottom 5%
Low range Average High range
Drug Manufacturers - Specialty & Generic 초소형주 median 1.82x · Bottom 1% — expensive within the industry
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
Analyst target price (reference)
$240.00 vs. current price +21918.3%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Drug Manufacturers - Specialty & Generic 초소형주

Who owns it?

Ownership flow is positive
Institutional modest net buying +0.6% · Short interest fell -4.6%p over the last 78 days
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-
No trading data for Insiders
🏦 Institutions (funds & investors)
+0.6%
Institutions net buying
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 11.5%
Retail-led
Healthcare 초소형주 Median 14.2%
🧑‍💼 Insiders 0.0%
Low, common among large-caps
Healthcare 초소형주 Median 16.1%
👤 Retail investors (estimated) 88.5%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
-
Past 78 days 📉 -4.6%p decrease
Short interest days to cover
0.1 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 0.0M주
Float (tradable shares) -
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 78 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
PRFX PRFX This Stock
$3.3M- 0.1 ▲- - -4.0%
LLY
$1.13T43.1 ▼36.2 ▼107.64% ▲0.58% ▼+0.1%
JNJ
$640.9B30.8 ▼7.5 ▼25.74% ▲2.02% ▲+1.0%
ABBV
$453.9B126.7 ▼- 15221.82% ▲2.67% ▲-0.9%
UNH
$379.3B26.9 ▼3.9 ▼12.49% ▲2.16% ▲-0.7%
MRK
$323.0B36.8 ▼7.0 ▼18.97% ▲2.5% ▲-0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen
→

Related News & Content

📖 Company overview
PRF 테크놀로지스(PRFX) 뭐하는 회사일까? - 주가 전망·실적·시총·관련주·본사 총정리
약물 전달 플랫폼 개발사. PRF-110(통증관리), OcuRing-K(안과), DeepSolar(AI태양광). 양의 현금 흐름 유지. 다각화 전략.
📚 Related Investment Guides
미국주식 세금 총정리 2026 — 초보자를 위한 계산법과 절세 전략
2026년 미국주식 세금 총정리. 양도소득세 22% 계산법, 배당세 15% 원천징수, 손익통산, 절세 전략까지. 실제 금액 시뮬레이션과 세금 계산기로 내 세금을 직접 확인해보세요.

FAQ

What kind of company is 프리에프 테크놀러지즈(PRFX)?

프리에프 테크놀러지즈(PRFX) belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is the market cap of PRFX?

The market cap of PRFX is approximately $3M, ranking 5,756 within its sector.

What is the 52-week high and low for PRFX?

PRFX has recorded a 52-week high of $17.95 and a low of $1.10.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.